{"id":98847,"date":"2024-03-19T12:35:00","date_gmt":"2024-03-19T11:35:00","guid":{"rendered":"https:\/\/cms.munich-startup.net\/?p=98847"},"modified":"2024-03-19T09:38:12","modified_gmt":"2024-03-19T08:38:12","slug":"tubulis-series-b-128-million","status":"publish","type":"post","link":"https:\/\/cms.munich-startup.net\/en\/98847\/tubulis-series-b-128-million\/","title":{"rendered":"Tubulis increases Series B to 128 million euros"},"content":{"rendered":"
\n

EQT Life Sciences and Nextech Invest Ltd are leading Tubulis\u2019 current financing round. numerous existing investors<\/a> such as Bayern Kapital, Biomedpartners, Coparion, High-Tech Gr\u00fcnderfonds (HTGF), Occident, and Seventure Partners. Two new US investors are also joining the team: Frazier Life Sciences and Deep Track Capital.<\/p>\n\n\n\n

The Biotech<\/a> develops antibody-drug conjugates (ADCs) that can attack cancer cells more specifically than before, without damaging the surrounding tissue. The drug is combined with an antibody that can distinguish cancer cells from healthy cells. This allows ADCs to not only fight cancer more precisely and efficiently, but also significantly reduce the side effects of therapy. Previous ADCs often lost a large portion of their active ingredients before reaching the tumor cell. Tubulis' ADCs deliver these drugs more reliably to their target.<\/p>\n\n\n\n

Tubulis plans to use the funds from the current financing round to complete the first clinical evaluation of its two lead ADC candidates, TUB-030 and TUB-040. The money will also be used to further develop Tubulis' technology platform for the development of additional, flexibly adaptable ADCs. Parallel to the entry of the new US investors, Tubulis plans to the startup<\/a> Furthermore, to expand its corporate presence by establishing a US subsidiary.<\/p>\n\n\n\n

"The current financing round from various international investors specializing in the biotech segment further underscores Tubulis' unique positioning in the ADC space. Our proprietary platform technology and expertise form the basis for a pipeline of specialized protein-drug conjugates,"<\/p><\/blockquote>\n\n\n\n

says Dominik Schumacher<\/strong>, CEO and co-founder of Tubulis.<\/p>\n\n\n\n

"Our goal is to establish Tubulis as a global leader in ADC development. Our next step will be to complete the clinical phase to unlock the full power and therapeutic value of ADCs."<\/p><\/blockquote>\n<\/div>","protected":false},"excerpt":{"rendered":"

Tubulis is working on special antibody-drug conjugates for cancer therapy. The Munich-based biotech company has now completed an expanded and oversubscribed Series B2 financing round of \u20ac128 million.<\/p>","protected":false},"author":42,"featured_media":90782,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[5633,1],"tags":[52,4001],"acf":[],"yoast_head":"\nTubulis stockt Series-B auf 128 Millionen Euro auf - Munich Startup<\/title>\n<meta name=\"description\" content=\"Das M\u00fcnchner Biotech Tubulis konnte eine erweiterte und \u00fcberzeichnete Series-B2-Finanzierungsrunde in H\u00f6he von 128 Millionen Euro abschlie\u00dfen.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cms.munich-startup.net\/en\/98847\/tubulis-series-b-128-million\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Tubulis stockt Series-B auf 128 Millionen Euro auf - Munich Startup\" \/>\n<meta property=\"og:description\" content=\"Das M\u00fcnchner Biotech Tubulis konnte eine erweiterte und \u00fcberzeichnete Series-B2-Finanzierungsrunde in H\u00f6he von 128 Millionen Euro abschlie\u00dfen.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cms.munich-startup.net\/en\/98847\/tubulis-series-b-128-million\/\" \/>\n<meta property=\"og:site_name\" content=\"Munich Startup\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/munichstartup\/\" \/>\n<meta property=\"article:published_time\" content=\"2024-03-19T11:35:00+00:00\" \/>\n<meta name=\"author\" content=\"Saskia Doll\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@munich_startup\" \/>\n<meta name=\"twitter:site\" content=\"@munich_startup\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Saskia Doll\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cms.munich-startup.net\/98847\/tubulis-series-b-128-millionen\/\",\"url\":\"https:\/\/cms.munich-startup.net\/98847\/tubulis-series-b-128-millionen\/\",\"name\":\"Tubulis stockt Series-B auf 128 Millionen Euro auf - Munich Startup\",\"isPartOf\":{\"@id\":\"https:\/\/cms.munich-startup.net\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/cms.munich-startup.net\/98847\/tubulis-series-b-128-millionen\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/cms.munich-startup.net\/98847\/tubulis-series-b-128-millionen\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2023\/04\/Tubulis-Management-April-2023.jpg\",\"datePublished\":\"2024-03-19T11:35:00+00:00\",\"author\":{\"@id\":\"https:\/\/cms.munich-startup.net\/#\/schema\/person\/a297bffde6879f56c9ff7b04d9af60b5\"},\"description\":\"Das M\u00fcnchner Biotech Tubulis konnte eine erweiterte und \u00fcberzeichnete Series-B2-Finanzierungsrunde in H\u00f6he von 128 Millionen Euro abschlie\u00dfen.\",\"breadcrumb\":{\"@id\":\"https:\/\/cms.munich-startup.net\/98847\/tubulis-series-b-128-millionen\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cms.munich-startup.net\/98847\/tubulis-series-b-128-millionen\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cms.munich-startup.net\/98847\/tubulis-series-b-128-millionen\/#primaryimage\",\"url\":\"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2023\/04\/Tubulis-Management-April-2023.jpg\",\"contentUrl\":\"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2023\/04\/Tubulis-Management-April-2023.jpg\",\"width\":2400,\"height\":1600,\"caption\":\"Tubulis\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/cms.munich-startup.net\/98847\/tubulis-series-b-128-millionen\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/cms.munich-startup.net\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Tubulis stockt Series-B auf 128 Millionen Euro auf\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cms.munich-startup.net\/#website\",\"url\":\"https:\/\/cms.munich-startup.net\/\",\"name\":\"Munich Startup\",\"description\":\"Das offizielle Startup-Portal f\u00fcr M\u00fcnchen\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cms.munich-startup.net\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/cms.munich-startup.net\/#\/schema\/person\/a297bffde6879f56c9ff7b04d9af60b5\",\"name\":\"Saskia Doll\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cms.munich-startup.net\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/3cbbe2dd459d277864bc6c7477d0bdf8?s=96&d=blank&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/3cbbe2dd459d277864bc6c7477d0bdf8?s=96&d=blank&r=g\",\"caption\":\"Saskia Doll\"},\"url\":\"https:\/\/cms.munich-startup.net\/en\/author\/doll\/\"}]}<\/script>\n<meta property=\"og:image\" content=\"https:\/\/cms.munich-startup.net\/en\/wp-content\/uploads\/2023\/04\/Tubulis-Management-April-2023.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2400\" \/>\n\t<meta property=\"og:image:height\" content=\"1600\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Tubulis increases Series B to \u20ac128 million - Munich Startup","description":"Munich-based biotech Tubulis has completed an expanded and oversubscribed Series B2 financing round of EUR 128 million.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cms.munich-startup.net\/en\/98847\/tubulis-series-b-128-million\/","og_locale":"en_US","og_type":"article","og_title":"Tubulis stockt Series-B auf 128 Millionen Euro auf - Munich Startup","og_description":"Das M\u00fcnchner Biotech Tubulis konnte eine erweiterte und \u00fcberzeichnete Series-B2-Finanzierungsrunde in H\u00f6he von 128 Millionen Euro abschlie\u00dfen.","og_url":"https:\/\/cms.munich-startup.net\/en\/98847\/tubulis-series-b-128-million\/","og_site_name":"Munich Startup","article_publisher":"https:\/\/www.facebook.com\/munichstartup\/","article_published_time":"2024-03-19T11:35:00+00:00","author":"Saskia Doll","twitter_card":"summary_large_image","twitter_creator":"@munich_startup","twitter_site":"@munich_startup","twitter_misc":{"Written by":"Saskia Doll","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/cms.munich-startup.net\/98847\/tubulis-series-b-128-millionen\/","url":"https:\/\/cms.munich-startup.net\/98847\/tubulis-series-b-128-millionen\/","name":"Tubulis increases Series B to \u20ac128 million - Munich Startup","isPartOf":{"@id":"https:\/\/cms.munich-startup.net\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cms.munich-startup.net\/98847\/tubulis-series-b-128-millionen\/#primaryimage"},"image":{"@id":"https:\/\/cms.munich-startup.net\/98847\/tubulis-series-b-128-millionen\/#primaryimage"},"thumbnailUrl":"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2023\/04\/Tubulis-Management-April-2023.jpg","datePublished":"2024-03-19T11:35:00+00:00","author":{"@id":"https:\/\/cms.munich-startup.net\/#\/schema\/person\/a297bffde6879f56c9ff7b04d9af60b5"},"description":"Munich-based biotech Tubulis has completed an expanded and oversubscribed Series B2 financing round of EUR 128 million.","breadcrumb":{"@id":"https:\/\/cms.munich-startup.net\/98847\/tubulis-series-b-128-millionen\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cms.munich-startup.net\/98847\/tubulis-series-b-128-millionen\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cms.munich-startup.net\/98847\/tubulis-series-b-128-millionen\/#primaryimage","url":"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2023\/04\/Tubulis-Management-April-2023.jpg","contentUrl":"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2023\/04\/Tubulis-Management-April-2023.jpg","width":2400,"height":1600,"caption":"Tubulis"},{"@type":"BreadcrumbList","@id":"https:\/\/cms.munich-startup.net\/98847\/tubulis-series-b-128-millionen\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cms.munich-startup.net\/"},{"@type":"ListItem","position":2,"name":"Tubulis stockt Series-B auf 128 Millionen Euro auf"}]},{"@type":"WebSite","@id":"https:\/\/cms.munich-startup.net\/#website","url":"https:\/\/cms.munich-startup.net\/","name":"Munich Startup","description":"The official startup portal for Munich","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cms.munich-startup.net\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/cms.munich-startup.net\/#\/schema\/person\/a297bffde6879f56c9ff7b04d9af60b5","name":"Saskia Doll","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cms.munich-startup.net\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/3cbbe2dd459d277864bc6c7477d0bdf8?s=96&d=blank&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/3cbbe2dd459d277864bc6c7477d0bdf8?s=96&d=blank&r=g","caption":"Saskia Doll"},"url":"https:\/\/cms.munich-startup.net\/en\/author\/doll\/"}]},"og_image":[{"width":2400,"height":1600,"url":"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2023\/04\/Tubulis-Management-April-2023.jpg","type":"image\/jpeg"}]},"_showyear":"","_inactive":"","_show_financing":"","_hide_on_map":"","_edit_lock":"1710837519:33","_edit_last":"33","_yoast_wpseo_focuskw":"Tubulis","_yoast_wpseo_metadesc":"Das M\u00fcnchner Biotech Tubulis konnte eine erweiterte und \u00fcberzeichnete Series-B2-Finanzierungsrunde in H\u00f6he von 128 Millionen Euro abschlie\u00dfen.","_yoast_wpseo_linkdex":"74","_thumbnail_id":"90782","wbounce_status":"default","_yoast_wpseo_primary_category":"5633","_yoast_wpseo_focuskw_text_input":"","_yoast_wpseo_content_score":"60","ms_image_format":"contentwidth","_ms_image_format":"field_5cb8587572c8b","ms_dachzeile":"","_ms_dachzeile":"field_5cd9b7f365df5","ms_bump_post_date":"","_ms_bump_post_date":"field_5d1341edcf42a","guest_author_name":"","_guest_author_name":"field_5cee78a6016f9","guest_author_image":"","_guest_author_image":"field_5cee7914016fb","guest_author_description":"","_guest_author_description":"field_5cee78dd016fa","ms_post_image_caption":"","_ms_post_image_caption":"field_5f735b0735284","ms_post_image_credit":"","_ms_post_image_credit":"field_5f735b1435285","suppress_startupbox":"0","_suppress_startupbox":"field_60a64b0b6efc6","_yoast_wpseo_estimated-reading-time-minutes":"2","_wp_old_date":"","_yoast_wpseo_title":"","_yoast_wpseo_wordproof_timestamp":"","footnotes":"","easy_language_simplification_original_id":"","easy_language_source_language":"","easy_language_simplification_language":"","easy_language_api":"","easy_language_prevent_automatic_mode":"","_wp_old_slug":"","_wp_trash_meta_status":"","_wp_trash_meta_time":"","easy_language_simplification_state_changed_from":"","easy_language_de_EL_changed":"","ms_competition_deadline":"","_ms_competition_deadline":"","_wpbitly":"","enclosure":"","_yoast_wpseo_meta-robots-noindex":"","_yoast_wpseo_meta-robots-nofollow":"","wbounce_template":"","wbounce_title":"","wbounce_text":"","wbounce_cta":"","wbounce_url":"","wbounce_override":"","_yoast_wpseo_opengraph-title":"","_yoast_wpseo_opengraph-description":"","_oembed_7131efca3705e16bd9da2c41df237660":"","_oembed_time_7131efca3705e16bd9da2c41df237660":"","_pprredirect_type":"","_pprredirect_url":"","_yoast_wpseo_opengraph-image":"","_yoast_wpseo_opengraph-image-id":"","_newsletterglue":"","easy_language_text_language":"","_wp_desired_post_slug":"","_relevanssi_noindex_reason":"","_links":{"self":[{"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/posts\/98847"}],"collection":[{"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/users\/42"}],"replies":[{"embeddable":true,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/comments?post=98847"}],"version-history":[{"count":4,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/posts\/98847\/revisions"}],"predecessor-version":[{"id":98854,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/posts\/98847\/revisions\/98854"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/media\/90782"}],"wp:attachment":[{"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/media?parent=98847"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/categories?post=98847"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/tags?post=98847"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}